UK & International Peptide Index & Citations45+ synthetic compounds · 300+ PubMed studies indexed →
TRUSTLYPHARMAUK & Global Peptide Index
Growth Hormone Secretagogues & GHRHCAS: 170851-70-4
Mixed / In Vivo Evidence

Ipamorelin

Aib-His-D-2-Nal-D-Phe-Lys-NH2 Pentapeptide GHSR Agonist

Ipamorelin is a synthetic pentapeptide and selective ghrelin/growth hormone secretagogue receptor 1a (GHSR-1a) agonist. It demonstrates exquisite somatotroph selectivity, eliciting endogenous growth hormone pulses without significantly raising adrenocorticotropic hormone (ACTH), cortisol, prolactin, or aldosterone.

Key Preclinical & Chemical ParametersAnalytical Baseline
Primary Target AxisSelective agonism of pituitary and hypothalamic GHSR-1a receptors, activating phospholipase C (PLC) pathways.
Lyophilized Storage-20°C dry
Purity Assay BaselineRP-HPLC ≥98.0% · ESI-MS
Standard DiluentBacteriostatic Water USP

Indexed for laboratory in vitro receptor binding assays and cellular synthesis research. Commercial materials are procured as non-clinical reagents under verified laboratory standards.

Molecular Anatomy

Chemical Structure & Metrics

Verified CAS
Empirical Molecular Formula:C38H49N9O5
Molecular Weight711.86 g/mol
Residue Length5 Residues
CAS Registry:170851-70-4
PubChem CID:9831659
Biochemical Class:Growth Hormone Secretagogues & GHRH
N-to-C Residue Chain Preview:
AibHisD-2-NalD-PheLys-NH2
Assay Standard:RP-HPLC ≥98% · ESI-MS
Executive Biochemical Summary

Structured Chemical & Preclinical Profile

PubChem & PubMed Indexed

1. Chemical Identity & Sequence Architecture

Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2 Pentapeptide GHSR Agonist) is an analytically characterized peptide with empirical formula C38H49N9O5 (MW 711.86 g/mol). CAS Registry: 170851-70-4.

2. Primary Preclinical Signaling Axis

Investigated in preclinical assays for cellular signaling: Selective agonism of pituitary and hypothalamic GHSR-1a receptors, activating phospholipase C (PLC) pathways.

3. Physical Formats & Delivery Matrices

Synthesized predominantly as high-purity lyophilized powder cakes, with secondary pre-metered pen cartridges and solution atomizers cataloged across vendors.

4. Reconstitution & Analytical Handling

Recommended reconstitution with Bacteriostatic Water USP. Lyophilized cake stored at -20°C dry. Solution stable at 2°C to 8°C refrigerated (stable 28 days).

Primary Amino Acid Sequence(5 Residues)
Nonpolar Polar Basic Acidic
H₂N-
1Aib
-
2His
-
3D-2-Nal
-
4D-Phe
-
5Lys-NH2
-COOH
Systematic IUPAC notation: Aib-His-D-2-Nal-D-Phe-Lys-NH2 Pentapeptide GHSR Agonist
Preclinical Data & Handling

Signaling Pathways & Laboratory Handling Protocols

Documented Receptor Pathways & In Vitro Signaling

1

Selective agonism of pituitary and hypothalamic GHSR-1a receptors, activating phospholipase C (PLC) pathways.

2

Intracellular inositol trisphosphate (IP3) generation prompting controlled calcium release and GH vesicle exocytosis.

3

Absolute lack of stimulatory activity at ghrelin receptors regulating appetite or gastrointestinal hypermotility in standard assays.

4

Synergistic amplification of GH release when co-administered with GHRH analogs like CJC-1295.

Investigation Scope

Regarded in peptide pharmacological literature as the cleanest third-generation secretagogue with zero significant binding affinity at off-target neuroendocrine receptors.

Handling Parameters

Recommended DiluentBacteriostatic Water USP
Lyophilized Storage-20°C dry
Reconstituted Storage2°C to 8°C refrigerated (stable 28 days)
Stability WindowStable under refrigeration; keep away from heating elements
INTERACTIVE LABORATORY DILUTION TOOL

Peptide Dilution & Reconstitution Calculator

Compute stock concentrations, micro-pipetting draw volumes, and U-100 syringe units with zero procedural guesswork.

5 mg
2 mL
200 mcg
100 Units Capacity
Dilution Formula Derivation:
Concentration =5,000 mcg÷2 mL=2500 mcg/mL
Draw Volume =200 mcg÷2500 mcg/mL=0.080 mL(8.0 Units)
Volumetric Dispensing CalibrationU-100 Standard
Draw to on 1 mL U-100 Syringe:
8.0 Units
Exact Liquid Volume: 0.080 mL (approx. 8 tick marks)
0 UBarrel Fill: 8%100 U
Stock Concentration2.50 mg/mL(2500 mcg/mL)
Aliquot Yield Per Vial25 Aliquots(5,000 mcg total)
Laboratory Reconstitution Protocol:

Slowly introduce bacteriostatic diluent against the internal glass vial wall. Swirl gently in a circular horizontal rotation. Never shake or vortex vigorously to prevent mechanical shearing of delicate peptide bonds. Store reconstituted stock at 2°C–8°C.

Verified Reagent Partners & Vendors

Partner & Vendor Catalogues for Ipamorelin

Independent partner directory providing research-grade lyophilized vials, cartridges, atomizers, and reconstitution solvents.

5 Verified Partner Catalogues
PharmaGrade logo
PharmaGradepharmagrade.store
Category Hub (All Formats)·United Kingdom / Worldwide

Category hub featuring research-grade lyophilized vials, pens, and blends.

Catalog Purity Spec≥99.2% (HPLC)
Product FormatAll Available Formats
Direct Peptides logo
Direct Peptidesdirect-peptides.com
Category Hub (All Formats)·Worldwide

Full catalogue category hub with multiple mg vial sizes and blends.

Catalog Purity Spec≥99.1% (HPLC)
Product FormatAll Available Formats
Direct Sarms logo
Direct Sarmsdirect-sarms.com
Category Hub (All Formats)·United Kingdom / International

Dedicated category hub listing research vials and cartridges.

Catalog Purity Spec≥98.9% (HPLC)
Product FormatAll Available Formats
Peptide Works logo
Peptide Workspeptide-works.com
Category Hub (All Formats)·United Kingdom / EU

UK-stocked research reagent catalogue hub featuring batch-verified peptide lots.

Catalog Purity Spec≥99.0% (HPLC)
Product FormatAll Available Formats
PharmaLab Global logo
PharmaLab Globalpharmalabglobal.com
Category Hub (All Formats)·Global Dispatch

Global catalogue hub including international dispatch batches.

Catalog Purity Spec≥99.3% (HPLC)
Product FormatAll Available Formats
Peer-Reviewed Literature

Academic Bibliography & Preclinical Studies for Ipamorelin

Primary academic indexing sourced from PubMed and peer-reviewed biotechnology journals documenting molecular mechanisms and in vitro cellular response.

3 Indexed Papers

Ipamorelin, the first selective growth hormone secretagogue

European Journal of Endocrinology·Published: 1998·Authors: Raun K, Hansen BS, Johansen PB, Thøgersen H, et al.
Documented Laboratory Observation:Confirmed selective GH release with absolute absence of ACTH, cortisol, or prolactin elevation in in vivo and in vitro paradigms.

Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers

Pharmaceutical Research·Published: 1999·Authors: Gobburu JV, Agersø H, Jusko WJ, Ynddal L.
Documented Laboratory Observation:Established clean linear pharmacokinetics and rapid clearance profiles without accumulation across human cohorts.

Ipamorelin, a new growth-hormone secretagogue, induces longitudinal bone growth in rats

Growth Hormone & IGF Research·Published: 1999·Authors: Johansen PB, Nowak J, Skjaerbaek C, Flyvbjerg A, et al.
Documented Laboratory Observation:Quantified significant increase in tibial longitudinal bone growth rate without perturbing plasma IGF-I binding protein profiles.
BIOCHEMICAL REFERENCE Q&A

Frequently Asked Chemical & Analytical Questions

Authoritative scientific clarifications regarding Ipamorelin classification, molecular pathways, and laboratory protocols.

4 Curated Questions

Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2 Pentapeptide GHSR Agonist) is an analytically characterized peptide compound with empirical molecular formula C38H49N9O5 and molecular weight 711.86 g/mol. It is indexed under CAS Registry Number 170851-70-4 and categorized in research literature under Growth Hormone Secretagogues & GHRH.

DirectoryCalculatorRegulatoryVendors